Coronavirus (COVID-19) information for GPs


You can find all RACGP COVID-19 resources in a central location on the RACGP website

The information on this page was last updated on Friday 11 June 2021, 3. 00 pm AEST.
Recent updates include:

Maintaining COVID-19 vigilance and testing
We remind GPs across the country to remain vigilant for symptoms of COVID-19 in yourselves and your patients. Anyone with symptoms consistent with COVID-19 – no matter how mild – should immediately self-isolate and get tested. Please remind all patients they must remain at home until they receive their negative result.

Access specific information for your state or territory


Find information on the vaccine rollout in Australia on the COVID-19 vaccine information for GPs webpage.

Please note that some states and territories have implemented different criteria. Please see your state of territory department of health guidance for further confirmation.


The Communicable Diseases Network Australia (CDNA) National Guidelines for Public Health Units define confirmed, probable and suspected cases as:

Confirmed case

A person who:
i. tests positive to a validated specific SARS-CoV-2 nucleic acid test1;
OR
ii. has the virus isolated in cell culture, with PCR confirmation using a validated method;
OR
iii. SARS-CoV-2 IgG seroconversion or a four-fold or greater increase in SARS-CoV-2 antibodies of any immunoglobulin subclass including ‘total’ assays in acute and convalescent sera, in the absence of vaccination2

Historical case

A historical case requires laboratory suggestive evidence AND either:

  • i. previous (prior to the past 14 days) clinical evidence OR
  • ii. previous (prior to the past 14 days) epidemiological evidence.

A historical case should not have symptoms of COVID-19 (or not have had symptoms of COVID-19 for the past 14 days).

See the Guidelines for evidence definitions.

Both confirmed cases and historical cases should be notified and reported​.

Suspect case

Clinical and public health judgement should be used in assessing if hospitalised patients with nonspecific signs of infection and patients who do not meet the clinical or epidemiological criteria should be considered suspect cases.​

A person who meets the following clinical AND epidemiological criteria:

Clinical Criteria:
Fever (≥38°C) or history of fever (e.g. night sweats, chills) OR acute respiratory infection (e.g. cough, shortness of breath, sore throat) OR loss of smell or loss of taste.

Epidemiological criteria:
 
In the 14 days prior to illness onset:

  • Close contact (see Contact definition below) with a confirmed or probable case
  • International travel
  • Workers supporting designated COVID-19 quarantine and isolation services
  • International border staff
  • Air and maritime crew
  • Health, aged or residential care workers and staff with potential COVID-19 patient contact
  • People who have been in a setting where there is a COVID-19 case
  • People who have been in areas with recent local transmission of SARS-CoV-263


Notes:

There is possibility for false negative PCR results in children, as there have been some instances where children have been found to mount a brisk immune response that is highly effective in restricting virus replication, resulting in a lower viral load (38). PHUs may seek serological evidence of SARS-CoV-2 immunity in symptomatic children who are repeatedly PCR negative but are known primary close contacts.
Antibody detection must be by a validated assay and included in an external quality assurance program. For all serological responses to be counted as laboratory evidence, a person should not have had a recent history of COVID-19 vaccination
3 For further information on geographically localised areas with elevated risk of community transmission, refer to the Department of Health website.

A primary close contact is defined as a person who has:

  • had face-to-face contact of any duration or shared a closed space (for at least 1 hour) with a confirmed case during their infectious period (from 48 hours before onset of symptoms until the case is no longer infectious (refer to Release from isolation)). 
  • the exposure may be any duration depending on risk setting such as: transmission has already been proven to have readily occurred, there are concerns about adequate air exchange in an indoor environment or concerns about the nature of contact in the place of exposure (e.g. the contact has been exposed to shouting or singing)
  • been exposed to a setting or exposure site where there is a high prevalence of infection e.g. a country where there is community transmission of COVID-19, or unprotected exposure in a quarantine hotel for returned travelers
  • been in a venue where transmission has been demonstrated to have occurred during the time frame in which the transmission would be expected to have occurred.
If the case is asymptomatic, see PCR positive tests in asymptomatic or pre-symptomatic persons for information on determining the asymptomatic (or pre-symptomatic) case’s infectious period and to inform identification of contacts.

Contact needs to have occurred within the infectious period of the case: a period extending from 48 hours before onset of symptoms in the case until the case is classified as no longer infectious. More conservative periods (e.g. 72 hours prior to illness onset) may be considered in high risk settings, at the discretion of the PHU.

Note that healthcare workers and other contacts who have taken recommended infection control precautions, including the use of appropriate PPE, while caring for an infectious confirmed COVID-19 case are not considered to be close contacts.

 

 

GPs should treat and test suspected COVID-19 patients in line with the advice from their local public health unit.  
Practices should not conduct consultations or carry out testing on suspected patients if they do not have the appropriate PPE.  Refer these patients to a local GP-led respiratory clinic or testing centre. 


Guidance on the use of personal protective equipment (PPE) for health care workers in the context of COVID-19 was released by the Department of Health on 10 June 2021. The recommendations were developed with advice from the National COVID-19 Clinical Evidence Taskforce Infection Prevention and Control Panel (IPC Panel) - NEW


Initial assessment

Consider initial screening of patients via a phone or video consultation using the National COVID-19 Clinical Evidence Taskforce flowchart: Assessment for suspected COVID-19 (V3.1 Published 26 November 2020).   

Only follow up with a face-to-face assessment if a diagnosis of moderate or severe illness cannot be confidently excluded via telehealth assessment. Patients who meet the criteria and who require a face-to-face consultation, should be asked not to enter the practice until precautions are put in place. NB: Patients with severe symptoms suggestive of pneumonia should be managed in hospital. 

Further assessment

Upon presentation of a person who is under quarantine or investigation, is a suspected or confirmed case of COVID-19 or has respiratory symptoms:

Specimen collection

Collect the specimen as as per the COVID-19 swab collection: Upper respiratory specimen infographic
  • To collect upper respiratory swabs, stand slightly to the side of the patient to avoid exposure to respiratory secretions, should the patient cough or sneeze.
  • Encourage the patient to maintain a slow breathing pattern and not hold the breath as this reduces the likelihood of gagging.
Self-collection of a nasal swab is acceptable, with appropriate supervision by a healthcare worker.


For a detailed description of methods of specimen collection for diagnosis of COVID-19 see: Public Health Laboratory Network guidance on laboratory testing for SARS-CoV-2

At the conclusion of the consultation

  • Remove PPE and perform hand hygiene
  • Room surfaces should be wiped with detergent/disinfectant by a person wearing gloves, surgical mask and eye protection.
  • Note that, for droplet precautions, a negative pressure room is not required and the room does not need to be left empty after sample collection.
 

If GPs and practice staff have worn PPE when dealing with a patient who is then confirmed as having the virus this is not considered a close contact so self isolation for 14 days is not required. 
 


The National COVID-19 Clinical Evidence Taskforce, of which the RACGP is a collaborating partner, has living guidelines on the management of adults with mild COVID-19. 

Access the clinical flowcharts for:

See all living guidelines.

The RACGP has develoved Home-care guidelines for adult patients with mild COVID-19 to help you support patients who test positive for COVID-19 in their home. A guide, action plan and symptom diary is available to share with patients.

A new guide Caring for adult patients with post-COVID-19 conditions is now available.

Telehealth consultations requiring an interpreter:

The RACGP has released a guide to support GPs conduct telehealth consultations with patients requiring an interpreter

The Australian Government’s Translation and Interpreting Service (TIS) has a Doctor’s Priority Line, and as a GP you are eligible for a free TIS code. If not already registered, general practices can register by calling 1300 131 450 or by visiting the TIS website
 

Resources for GPs:

 

National multilingual resources:

 
  • **NEW** Maridulu Budyari Gumal SPHERE – 36 multilingual fact sheets containing medical advice and instructions during COVID-19 covering Arthritis, Asthma, Cardiovascular Health, Diabetes and Stroke translated into Arabic, Chinese, Chinese (Standard and Simplified), Greek, Italian and Vietnamese
  • Etholink Information in your language - translated information from federal, state, territory and local government and the World Health Organization
  • SBS Coronavirus information in your language – news and information about COVID-19 in 63 languages
  • Department of Home Affairs COVID-19 in your language – information on the current outbreak in multiple languages
  • Department of Health Translated resources – fact sheets and posters on the current outbreak in multiple languages
  • MyAus COVID-19 App – a multilingual resource for CALD communities on COVID-19 and available supports
 

State and territory multilingual resources:

New South Wales:

Queensland:

Victoria:

 

The RACGP has compiled a summary of links to information and resources to support people with disability during the COVID-19 pandemic.

New guidelines for the rights of people with disability during COVID-19

New guidelines have been developed by the Australian Human Rights Commission to support the rights of people with disability during the COVID-19 pandemic. 
The guidelines are designed to assist healthcare, disability services and support workers to take a human rights-based approach to decision-making during the pandemic. 

COVID-19 Health Professionals National Disability Advisory Service

GPs and other health professionals caring people with disability can now access a telephone advisory service being piloted to provide specialised clinical advice during the COVID-19 pandemic.  

The COVID-19 Health Professionals National Disability Advisory Service (managed by Healthdirect Australia on behalf of the Australian Department of Health) provides specialised advice regarding the care of a person with disability diagnosed with COVID-19 or experiencing COVID-19 symptoms. Some people with disability may require reasonable adjustments to their healthcare to ensure they receive, either COVID-19 testing or treatment, with minimum distress. The Advisory Service can provide specific support required to address communication and management issues, such as behaviours of concern and the reduction of risk to the patient and staff involved in the process.

The Advisory Service is staffed by health professionals with disability service qualifications and experience working with people with disability. To access the service call 1800 131 330. The service is available between 7.00 am - 11.00 pm (AEST) seven days a week. 
 

National Disability Insurance Scheme (NDIS)

 

NSW and Victoria NDIS participants can now claim for personal protective equipment (PPE)

Victoria and NSW NDIS participants can now recover the cost of purchasing PPE items if they receive an average of at least one hour a day of face-to-face daily living support. Previously, only participants who used PPE as a regular part of their support arrangements were able to access PPE through their NDIS funds.
Further information
 

Australian Government information/resources

 

Disability organisations

Disability service providers

 

 

National Aboriginal Community Controlled Health Organisation (NACCHO) resources

The National Aboriginal Community Controlled Health Organisation (NACCHO) are leading a COVID-19 Taskforce (the Taskforce) which includes government and member representatives.

It is recommended that members monitor the NACCHO Coronavirus site for updates and subscribe to the NACCHO Communique for the latest Aboriginal and Torres Strait Islander health sector news and information on COVID-19.


Recommendations for healthcare teams supporting prevention and management of COVID-19 for Aboriginal and Torres Strait Islander people

The RACGP, National Aboriginal Community Controlled Health Organisation (NACCHO), Lowitja Institute and Australian National University (ANU) are working together to develop a series of rolling, evidence-based recommendations to assist healthcare teams with the prevention and management of COVID-19 in Aboriginal Community Controlled Health Services and other primary care settings.

The guidance is available now through NACCHO’s online COVID-19 information hub and includes:


Australian Indigenous Doctors Association (AIDA) resources

Access to information and resources from the Australian Indigenous Doctors Association (AIDA) from the AIDA website.   

AIDA are conducting twice-weekly peer support forums for Aboriginal and Torres Strait Islander doctors. Please contact communications@aida.org.au for log-in details. 

 

Department of health resources

The Department of Health have released Coronavirus (COVID-19) resources for Aboriginal and Torres Strait Islander people and remote communities.
 

Management Plan for Aboriginal and Torres Strait Islander Populations

The ‘Management Plan for Aboriginal and Torres Strait Islander Populations’ has been developed by the Aboriginal and Torres Strait Advisory Group on COVID-19 and endorsed by the Australian Health Protection Principal Committee (AHPPC).

The Management Plan outlines key issues and considerations in planning, response and management of COVID-19 that need to be addressed at all levels of governance, in collaboration with key partners and stakeholders, including impacted communities.
 

 

 

Caring for yourself

During events such as the current coronavirus situation, additional pressure may be placed on GPs and practice staff as frontline workers through increased patient attendance to the practice, responding to fear and anxiety amidst the community and staying up to date as the situation evolves.

It is important during such times that GPs and practice staff take time to care for themselves and take the opportunity to debrief with colleagues. If you require additional support, services are available, specifically developed for doctors.
 

The Essential Network (TEN) for frontline workers

This new online e-mental health hub, developed by the Black Dog Institute, connects frontline healthcare workers with services to cope with the stress of the ongoing pandemic.   
 

DRS4DRS

You can also access support via the DRS4DRS website and state/territory based helplines. DRS4DRS is an independent program providing confidential support and resources to doctors and medical students across Australia, by doctors. Confidential phone advice is available 24/7 for any doctor or medical student in Australia via each state/territory helpline and referral service.
 

RACGP GP Support Program

Should you need support, don't hesitate to contact the RACGP GP Support Program. This is a free and confidential psychological support service available to all members, delivered by LifeWorks by Morneau Shepell. Access the service by calling 1300 361 008 (24 hours/7 days).
 

Immediate 24/7 supports

Beyond Blue Support Service - 1300 22 4636
Lifeline Crisis Support - 13 11 14
 

Providing mental health and wellbeing support to your patients

 

GPs play a critical role in the ongoing mental health and wellness of their patients. 

The General Practice Mental Health Standards Collaboration (GPMHSC) has collated important information to help you support and care for the mental health and wellbeing of your patients during the COVID-19 pandemic.

This includes:

New MBS items for additional psychological therapy sessions

Thirty-six new temporary mental health treatment Medicare Benefits Schedule (MBS) items have been introduced, which provide 10 additional Medicare-subsidised psychological therapy sessions for people affected by COVID-19.
The new items are available under the ‘Better Access to Psychiatrists, Psychologists and General Practitioners through the MBS’ initiative and will apply from 7 August 2020 to 31 March 2021. The additional sessions will allow eligible patients to continue to receive mental healthcare from their GP, psychologist or other eligible allied health worker.

The 10 additional sessions are available to:

  • patients in areas with public health orders that restrict movement within the state or territory at any time from 1 July 2020 to 31 March 2021 (eg lockdown or stay-at-home orders)

  • patients required to self-isolate or quarantine under public health orders for at least 14 days.

Find more information on the RACGP website, including descriptors and rebates for the six new items that support mental healthcare provided by GPs.
 

Completing Mental Health Skills Training (MHST)

Accredited MHST activities provide GPs with the skills and knowledge to assess, treat, plan and review mental health issues commonly presenting in general practice. Upon successful completion of MHST, GPs should be able to develop and review a GP Mental Health Treatment Plan (MHTP).

GPs can complete MHST by completing one of the following pathways:

  • MHST primary pathway, or;
  • MHST modular pathway.
The MHST primary pathway is a six-hour (at minimum) activity that can be completed online or face-to-face. It is designed for general practice registrars and other medical practitioners entering Australian general practice.

To satisfy the requirements of the MHST modular pathway, GPs must complete one Core Module (usually three hours) and one Clinical Enhancement Module (usually four hours). The MHST modular pathway is designed for more experienced GPs who assess, treat and manage complex mental health issues in their practices.

For additional information on the specific requirements for MHST pathways, download the Mental health training standards 2020–22: A guide for GPs.

View accredited MHST (primary pathway) courses
View accredited MHST (modular pathway) courses


Once both these activities are completed, please contact the General Practice Mental Health Standards Collaboration (GPMHSC) on 03 8699 0556 to ensure your Provider number is on file. This will enable the report of your completion to Medicare. Medicare advise four to six weeks processing time. Completion of these activities will make you eligible to access the higher rebate numbers 2715 and 2715 (and equivalent non-VR and telehealth numbers) for the preparation of a Mental Health Treatment Plan.

Completing Focussed Psychological Strategies Skills Training (FSS ST)

Completing an accredited FPS ST course and registering with Medicare as a GP provider of FPS, allows GPs to deliver evidence-based psychological interventions to their communities and important where shortages or lack of access to psychologists and psychiatrists exist, particularly in rural and remote settings.

  1. Complete an accredited MHST course
  2. Complete an accredited FPS ST course
  3. Complete application to register as a GP provider of FPS with Medicare Australia and attach certificate of completion to gpmhsc@racgp.org.au.
The GPMHSC Secretariat will forward your application to Medicare Australia. Medicare will confirm your eligibility to access MBS items 2721–2727 (or non-VR equivalent; 283–287). Please note: you cannot claim against these item numbers until you receive this letter. 

 


The RACGP acknowledges the significant impact and disruption that the COVID-19 pandemic will have on GPs working in rural and remote communities. Access up-to-date information via RACGP’s COVID-19 information for rural GPs webpage.


RACGP is committed to supporting its doctors in training and minimising disruption caused by COVID-19. Access up to date information via RACGP COVID-19 information for GPs in training webpage.

There is a need to find flexible solutions to COVID-19 pandemic-related disruption of education, training and assessment, while also ensuring that training standards are met. The RACGP provides guidelines for RTOs and RVTS in developing alternative models of training delivery that comply with the Vocational Training standards during the COVID-19 disruption. The guidelines are relevant for rural and general pathway registrars, as well as for those enrolled in FARGP. Access information about alternative models of vocational training delivery.
 
 

RACGP COVID-19 resources

You can now find all RACGP COVID-19 resources in one centralised location on the RACGP website. These resources cover:


CPR during the pandemic

The National COVID-19 Clinical Evidence Taskforce (of which the RACGP is a member), in partnership with the Infection Control Expert Group (ICEG), have published clinical flowcharts to guide clinicians and trained first aid responders in delivering potentially lifesaving CPR as safely as possible.

 

The John Murtagh Library: COVID-19 evidence and research resources

The John Murtagh Library has curated some resources on COVID-19 to help you find reliable evidence and research literature. These resources include evidence summaries, updated ebooks and texts, ‘live’ literature search links, research portals, and more.  

Access the library's COVID-19 subject portal